157 related articles for article (PubMed ID: 32546980)
1. Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
Pointreau Y; Bensadoun RJ; Bera G; Sire C; Ruffier A; Janoray G; Calais G; Bollet M; Pinel B; Braniste V; Amores X
Patient Prefer Adherence; 2020; 14():859-868. PubMed ID: 32546980
[TBL] [Abstract][Full Text] [Related]
2. Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.
Radbruch L; Torres LM; Ellershaw JE; Gatti A; Luis Lerzo G; Revnic J; Taylor D
Support Care Cancer; 2012 Mar; 20(3):565-73. PubMed ID: 21424794
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
Ueberall MA; Lorenzl S; Lux EA; Voltz R; Perelman M
J Pain Res; 2016; 9():571-85. PubMed ID: 27574463
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.
Portenoy RK; Burton AW; Gabrail N; Taylor D;
Pain; 2010 Dec; 151(3):617-624. PubMed ID: 20800358
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study.
Fallon M; Reale C; Davies A; Lux AE; Kumar K; Stachowiak A; Galvez R;
J Support Oncol; 2011; 9(6):224-31. PubMed ID: 22055892
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures.
Pardo J; Mena A; Jiménez E; Aymar N; Ortiz I; Roncero R; Mestre F; Vidal M
Clin Transl Oncol; 2019 Nov; 21(11):1568-1572. PubMed ID: 31093890
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients.
Portenoy RK; Raffaeli W; Torres LM; Sitte T; Deka AC; Herrera IG; Wallace MS;
J Opioid Manag; 2010; 6(5):319-28. PubMed ID: 21046929
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
Mercadante S; Aielli F; Adile C; Costanzi A; Casuccio A
J Pain Symptom Manage; 2016 Jul; 52(1):27-34. PubMed ID: 27208863
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl pectin nasal spray in breakthrough cancer pain.
Taylor D; Galan V; Weinstein SM; Reyes E; Pupo-Araya AR; Rauck R;
J Support Oncol; 2010; 8(4):184-90. PubMed ID: 20822038
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl pectin nasal spray for breakthrough cancer pain.
Taylor DR; Gabrail N
Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning.
Prieto I; Pardo J; Luna J; Marin JP; Olivera J; Garcia AJ; Perez AM
Scand J Pain; 2016 Apr; 11():52-58. PubMed ID: 28850470
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.
Mazzola R; Ricchetti F; Fiorentino A; Giaj-Levra N; Fersino S; Tebano U; Albanese S; Gori S; Alongi F
Clin Transl Oncol; 2017 May; 19(5):593-598. PubMed ID: 27853984
[TBL] [Abstract][Full Text] [Related]
13. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
Taylor D; Radbruch L; Revnic J; Torres LM; Ellershaw JE; Perelman M
J Pain Symptom Manage; 2014 Jun; 47(6):1001-7. PubMed ID: 24128821
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
Bossi P; Locati L; Bergamini C; Mirabile A; Granata R; Imbimbo M; Resteghini C; Licitra L
Oral Oncol; 2014 Sep; 50(9):884-7. PubMed ID: 25001894
[TBL] [Abstract][Full Text] [Related]
15. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
Mercadante S; Prestia G; Adile C; Casuccio A
J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
[TBL] [Abstract][Full Text] [Related]
16. Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer.
Torres LM; Revnic J; Knight AD; Perelman M
J Palliat Med; 2014 Oct; 17(10):1150-7. PubMed ID: 25211772
[TBL] [Abstract][Full Text] [Related]
17. Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer Pain.
Rauck R; Parikh N; Dillaha L; Barker J; Stearns L
Pain Pract; 2015 Jul; 15(6):554-63. PubMed ID: 25060406
[TBL] [Abstract][Full Text] [Related]
18. Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain.
Überall MA; Müller-Schwefe GH
Curr Med Res Opin; 2011 Jul; 27(7):1385-94. PubMed ID: 21561313
[TBL] [Abstract][Full Text] [Related]
19. Management of predictable pain using fentanyl pectin nasal spray in patients undergoing radiotherapy.
Bell BC; Butler EB
J Pain Res; 2013; 6():843-8. PubMed ID: 24376361
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
Mercadante S; Masedu F; Valenti M; Aielli F
Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
